Charming Medical Limited Class A Ordinary Shares
MCTA | NASDAQ
$29.36
$0.00 (+0.02%)
At close: Dec 9, 2025, 9:30 AM ET
$29.36
$0.00 (-0.02%)
After-hours:
Oct 28, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2024 Mar 31, 2025 | FY 2023 Mar 31, 2024 | FY 2022 Mar 31, 2023 |
|---|---|---|---|
Revenue | 6.22M | 6.02M | 3.53M |
Cost of Revenue | 2.04M | 2.1M | 2.04M |
Gross Profit | 4.18M | 3.91M | 1.49M |
Operating Income | 1.39M | 1.01M | -521.34K |
Interest Income | 64.14K | 19.51K | 10.29K |
Pretax Income | 1.44M | 1M | -420.47K |
Net Income | 1.2M | 777.81K | -305.12K |
Selling & General & Admin | 2.32M | 2.35M | 1.66M |
Research & Development | n/a | n/a | n/a |
Other Expenses | 474.14K | 555.41K | 353.39K |
Operating Expenses | 2.79M | 2.91M | 2.02M |
Interest Expense | 20.87K | 26.05K | 20.26K |
Selling & Marketing Expenses | 999.35K | 859.47K | 664.88K |
Cost & Expenses | 4.83M | 5.01M | 4.05M |
Income Tax Expense | 236.08K | 181.75K | -84.86K |
Shares Outstanding (Basic) | 16.94M | 16.94M | 16.94M |
Shares Outstanding (Diluted) | 16.94M | 16.94M | 16.94M |
EPS (Basic) | 0.07 | 0.05 | -0.02 |
EPS (Diluted) | 0.07 | 0.05 | -0.02 |
EBITDA | 1.72M | 1.42M | -189.13K |
EBIT | 1.46M | 1.03M | -400.21K |
Depreciation & Amortization | 263.45K | 391.7K | 211.08K |
Add to Watchlist
Select watchlists to add or remove MCTA